VVector Bio logo

VVector Bio jobs and careers

Canada

About VVector Bio

VVector Bio is helping biotech companies efficiently manufacture viral vectors for cell and gene therapy and vaccines using proprietary, cutting-edge technologies available for licensing. We have deep expertise in developing scalable processes for viruses used in these therapies and vaccines, including Adeno-associated virus (AAV), lentivirus (LVV), enveloped VLPs, adenovirus, and other virus-like particles such as NDV. Our processes are fully scalable and ready for transfer to a GMP facility. In the context of AAV, we are developing two proprietary manufacturing technologies aimed at improving and simplifying the manufacturing process. Our first technology is a single plasmid system, which optimizes the traditional three-plasmid transfection method, reducing overall costs by 20% and increasing AAV manufacturing yields by 5x. The second technology is a high-producer cell line capable of producing AAV at orders of magnitude higher yields than current industry standards.

Founded in 2019 by Alina Venereo- Sanchez.

Founded
2019
Employees
1 to 10
Total funding
$250K
Headquarters
Canada

Leadership

The top of VVector Bio's org chart, with how many people report into each leader.

AVPhoto of Alina Venereo-Sanchez

Alina Venereo-Sanchez

Chief Executive Officer

Jobs at VVector Bio

No open positions right now. Explore more companies on TheJobsMap.